3 ms·
A university doesn't want to spend $200 million to run the drug trials for a new drug. And I suspect university researchers don't want to spend their time manag
by marcinzm 7y ago
A university doesn't want to spend $200 million to run the drug trials for a new drug. And I suspect university researchers don't want to spend their time managing such trials either.
edit: The real problem is the lack of limits on marketing and advertising of drugs in the US. That's what's driving up the cost of drugs more than anything. Of course, without it drugs for rare conditions will never get made since there's no way to communicate their existence to patients. Ah well, nothing in life is perfect.
- unishark 7y agoIndustry labs compete for govt grants too. No reason why they can't keep developing the drugs. The USPTO has a budget of around $3.5B.
- amelius 7y ago> A university doesn't want to spend $200 million to run the drug trials for a new drug. And I suspect university researchers don't want to spend their time managing such trials either. Yes, so outsource the trials to academic hospitals or specialized companies. Pay them properly and don't grant them a patent based on just doing the trials (they are a lot of work but they are not an inventive step).